The total equity of Talis Biomedical with headquarters in the United States amounted to million U.S. dollars in 2023. The reported fiscal year ends on December 31.
Compared to the earliest depicted value from 2019 this is a total increase by approximately million U.S. dollars. The trend from 2019 to 2023 shows, however, that this increase did not happen continuously.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
U.S. Securities and Exchange Commission. (October 24, 2024). Total equity of Talis Biomedical from 2019 to 2023 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 15, 2026, from /statistics/1510330/talis-biomedical-total-equity/
U.S. Securities and Exchange Commission. "Total equity of Talis Biomedical from 2019 to 2023 (in million U.S. dollars)." Chart. October 24, 2024. ÌÇÐÄÆÆ½â°æ. Accessed July 15, 2026. /statistics/1510330/talis-biomedical-total-equity/
U.S. Securities and Exchange Commission. (2024). Total equity of Talis Biomedical from 2019 to 2023 (in million U.S. dollars). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 15, 2026. /statistics/1510330/talis-biomedical-total-equity/
U.S. Securities and Exchange Commission. "Total Equity of Talis Biomedical from 2019 to 2023 (in Million U.S. Dollars)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 24 Oct 2024, /statistics/1510330/talis-biomedical-total-equity/
U.S. Securities and Exchange Commission, Total equity of Talis Biomedical from 2019 to 2023 (in million U.S. dollars) ÌÇÐÄÆÆ½â°æ, /statistics/1510330/talis-biomedical-total-equity/ (last visited July 15, 2026)
Total equity of Talis Biomedical from 2019 to 2023 (in million U.S. dollars) [Graph], U.S. Securities and Exchange Commission, October 24, 2024. [Online]. Available: /statistics/1510330/talis-biomedical-total-equity/